In contrast, due to its unique inhibition mechanism, the Sirt1 inhibitor EX-527 [127] has nanomolar potency and translational potential in Huntington’s disease but is often used in cellular studies at micromolar concentrations that also inhibit Sirt2 [147,148,149,150]. Here, SIRT2 is linked to Huntington disease.